Jennifer Fitzpatrick is CLO at Sionna Therapeutics, Inc. (SION). They have made 1 open-market trade across 1 company since 2025, most recently 2026-09-17.
CIK 0002061851
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| SION | 28,133 | $110K |
Shares reported on the most recent Form 4, priced at the 2026-09-18 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SION | SELL · 10b5-1 | 2026-07-06 | 2026-07-07 | $43.60 | $447K | +9.4% | +9.8% | -89.3% |
| SION | SELL | 2026-03-05 | 2026-03-06 | $33.86 | $347K | -3.3% | +5.1% | +6.2% |
| SION | SELL · 10b5-1 | 2025-12-05 | 2025-12-09 | $40.52 | $831K | +3.3% | -10.8% | -8.5% |
| SION | SELL · 10b5-1 | 2025-09-04 | 2025-09-05 | $23.12 | $237K | -11.1% | +17.0% | +63.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.